Disc Medicine Inc at ASH Transcript
Good day, and thank you for standing by, welcome to Disc Medicine Investor Event at 2023 ASH. (Operator Instructions) Please be advised that today's conference is being recorded. It is now my pleasure to hand you over to Mr. John Quisel, CEO of Disc Medicine. Please go ahead, sir.
Hello, and welcome to the Disc Medicine 2023 ASH management call. This is John Quisel speaking, CEO here at Disc Medicine. And we put together a presentation today to review all of the data that we've been through at the ASH conference here today in San Diego.
And then we've also added a few extra elements to the presentation today. We'll walk through some additional data from the DISC-0974 Program, some additional information about the commercial opportunity for bitopertin, and we're delighted to have a guest speaker with us today, Dr. Bruce Wang from UCSF.
So that's the menu. I'll start by noting that there will be forward looking statements and it should be taken in context with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |